The company said the funding would be used to advance its main ProNutrien pipeline and develop more candidates for medical foods and supplements.
Pronutria chairman and Flagship CEO Noubar Afeyan said, “Pronutria has very effectively converted its unique vision into reality with multiple clinical candidates.
“The company has hit an important inflection point with a validated platform where it will rapidly advance its candidates in important medical areas initially as medical foods and dietary supplements and eventually as therapeutics.”
Flagship founded Pronutria in 2011 through Flagship VentureLabs. The latest financing round brings the company’s total funding to $23m.
Copyright © 2014 AltAssets